Study of 756,000 pregnancies: early exposure to Ozempic-type drugs linked to preterm birth only in women with diabetes
A Danish registry study analysed 756,636 pregnancies, 529 with possible exposure to semaglutide or liraglutide around conception.
A Danish registry study analysed 756,636 pregnancies, 529 with possible exposure to semaglutide or liraglutide around conception.
Australia's Therapeutic Goods Administration has approved a once-daily oral tablet form of semaglutide, sold as Wegovy.
In two phase 3 trials with more than 1,000 patients, the experimental drug retatrutide cut knee osteoarthritis pain by at least half in about two-thirds of people, versus 38% on placebo.
On 17 November 2026 WHO, UNICEF and Spain launched the call to action “Bending the curve by 2030”.
Allergan Aesthetics (AbbVie) presented 9 abstracts at ASDS 2026 in San Diego (5–8 November).
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one vial of NAD+ injection because their sterility cannot be assured.
Galderma, L'Oréal and Natura are testing treatments for facial sagging and volume loss in weight-loss drug users.
The UK medicines regulator and West Midlands Police seized more than 12,000 fake weight-loss pens in a raid on 14 October 2026.
A systematic review in Plastic and Reconstructive Surgery pooled 12 studies with 29,357 patients.
On 7 October 2026 WHO released its first global guidelines on caring for children and adolescents with obesity.
Nothing more to show